The 94 rating InvestorsObserver gives to Mereo BioPharma Group plc - ADR (MREO) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 100 percent of stocks in the Biotechnology industry, MREO’s 94 overall rating means the stock scores better than 94 percent of all stocks.
MREO has an Overall Score of 94. Find out what this means to you and get the rest of the rankings on MREO!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Mereo BioPharma Group plc - ADR Stock Today?
Mereo BioPharma Group plc - ADR (MREO) stock is trading at $2.19 as of 3:54 PM on Tuesday, Nov 7, a gain of $0.12, or 5.79% from the previous closing price of $2.07. The stock has traded between $2.06 and $2.39 so far today. Volume today is 1,513,637 compared to average volume of 1,745,629.
Click Here to get the full Stock Report for Mereo BioPharma Group plc - ADR stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
